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Until recently, osteocytes have escaped the limelight, embedded within their cave-like lacunae in the
mineralized matrix of bone. In this issue of Cell Metabolism, Tatsumi et al. (2007) present evidence
that this ‘‘third bone cell’’ can send either inhibitory signals to osteoclasts to maintain bone mass
with normal loading or stimulatory signals to osteoclasts to initiate bone loss upon immobilization,
thereby playing an indispensable role in skeletal homeostasis.Unlike the majority of organs in the
body, which are composed of ‘‘soft’’
tissue from which cells can easily be
isolated, the ‘‘hard’’ mineralized tissue
of bone has made it difficult to isolate
and study osteocytes. This is in con-
trast to osteoblasts and osteoclasts,
the cells responsible for bone for-
mation and resorption, respectively,
which are much more readily avail-
able. It was thought that osteocytes
are passive cells or ‘‘placeholders’’ in
bone or, conversely, that osteocytes
could potentially be mechanosensors
and transducers of mechanical load
through biochemical signals (reviewed
in Bonewald, 2006). A new study by
Tatsumi and coworkers (2007) now
sheds light on the role of osteocytes
in maintaining skeletal homeostasis
and regulating skeletal responses to
mechanical loading.
The skeleton has evolved to adjust
its bone mass and architecture in re-
sponse to load. Whereas more bone
is protective against fracture, it also
requires more energy to maintain. Pre-
sumably, an animal with heavier bones
would be less likely to escape preda-
tors than a lighter animal. Therefore,
loading, as occurs with exercise, in-
creases bone mass. Conversely, un-
loading, as occurs with space flight or
immobilization, results in bone loss.
This maintains a compromise between
having sufficient bone mass to with-
stand loading and at the same time
conserving energy. The complex lacu-
nocanalicular network connecting all
of the osteocytes within bone and cells
on the bone surface supports the idea
that these cells can sense loading on
the skeleton or its absence and then410 Cell Metabolism 5, June 2007 ª2007translate those signals to biochemical
signals of resorption or formation.
The paper by Tatsumi et al. (2007)
provides data showing that viable
osteocytes are necessary to send
signals to prevent bone loss under nor-
mal loading or ambulation and are also
necessary to activate bone loss in
response to unloading. The authors
used an ingenious approach to deter-
mine the role of osteocytes by loss-
of-function studies. Using mice carry-
ing a diphtheria toxin (DT) receptor
specifically expressed in osteocytes,
the authors were able to kill off osteo-
cytes using single injections of DT.
The investigators used the promoter
of dentin matrix protein 1 (DMP1),
which is highly and selectively ex-
pressed in osteocytes (Toyosawa
et al., 2001). They performed threema-
jor types of experiments: (1) injection
of DT into normal ambulatory mice,
(2) injection of DT just before hindlimb
unloading, and (3) a more complicated
experiment in which DT was injected
after hindlimb unloading and just be-
fore the mice were returned to normal
ambulation.
Two days after DT injection, 10-
week-old transgenic mice showed an
increase in mRNA for an activator of
osteoclasts (RANKL) and no change
in markers of osteoblasts (Runx2,
alkaline phosphatase/ALP, and OPG)
but significant reduction in a marker
of late osteoblasts (osteocalcin) and
markers of osteocytes (DMP1, E11/
gp38, MEPE, Phex, and SOST). Eight
days after DT injection, a dramatic in-
crease (70%–80%) in empty lacunae
was observed, as well as an increase
in osteoclast number and activity. AElsevier Inc.reduction in bone formation rate was
observed, even though no changes in
osteoblast number, their contact area
with bone, or isolated osteoblast func-
tion occurred. These results support
previous theories that viable osteo-
cytes prevent osteoclast activation
(Tomkinson et al., 1998) and that dying
or apoptotic osteocytes may send sig-
nals to recruit osteoclasts (Verborgt
et al., 2000). Dramatic bone loss was
observed at 40 days after DT injection
in 18-week-old transgenic mice with
complete recovery at 90 days. DT in-
jection 1 day before unloading by tail
suspension resulted in no loss of bone,
which supports observations of pre-
vious investigators that osteocytes
could send signals of bone resorption
with unloading (Aguirre et al., 2006)
(Figure 1A).
However, the results of the final ex-
periment (Figure 1B) were totally unex-
pected. In normal mice, bone loss
with unloading can be recovered with
normal ambulation. After 7 days of un-
loading, the transgenic animals re-
sponded with bone loss as expected,
but if given a DT injection between un-
loading and reloading, bone recovery
was normal, or even somewhat en-
hanced in some cases. This suggests
that bone recovery by reloading does
not depend on osteocytes. These re-
sults indicate that the mechanisms re-
sponsible for maintaining bone mass
with normal load are not the same as
those for recoveringbonemassafterun-
loading. Additional experiments will be
required to confirm this finding to rule
out possible differences in bone forma-
tion rates between wild-type and trans-
genics at 18 months of age. Also, it will
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whether the remaining 20%–
30% osteocytes are involved
in or responsible for this re-
covery in bone mass.
This elegant study is an
exciting start, unraveling
the biology of this previously
overlooked cell type, and
gives rise to a number of
new questions. Although
the targeted ablation of os-
teocytes shows that dead
or dying osteocytes result
in increased osteoclast ac-
tivity, previous studies have
suggested that both viable
and apoptotic osteocytes
can elicit osteoclast activa-
tion and targeted resorption
(Verborgt et al., 2002; Zhao
et al., 2002). Thedeathof os-
teocytes in the Tatsumi et al.
study could be overriding
their other functions, such
as support or inhibition of
osteoblast function, bone
formation, and bone miner-
alization, which should be
considered in the interpre-
tation of the phenotype. For
example, sclerostin, a
marker of mature embed-
ded osteocytes, normally
functions as an inhibitor of
bone formation (Poole
et al., 2005). Deletion or mu-
tation of DMP1 in osteocytes results in
osteomalacia and hypophosphatemia
(Feng et al., 2006). Ablation of the oste-
ocyte population would presumably
delete expression of a number of oste-
ocyte-specific genes simultaneously,
and therefore it is difficult to equate
the observed phenotype in the ab-
lated mice to alterations in osteocyte-
specific genes.
Another major question that begs to
be investigated is the nature of the
signal sent from the osteocyte and
the nature of its target. This signal
could be the focus of research to de-
velop therapeutic approaches for
modulating bone mass in diseases
such as osteoporosis and conditions
such as space flight. Similar to the pro-
verbial individual looking for lost keys
only in the lamplight, much
research thus far has fo-
cused on osteoblasts and
osteoclasts, as these are
easily accessible. The stud-
ies by Tatsumi et al. (2007)
have now significantly ex-
panded the illuminated
search area, bringing the os-
teocyte out of its ‘‘dark’’ cave
and into the ‘‘light’’ of scien-
tific scrutiny and discovery.
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Figure 1. Osteocytes Are Mechanosensors in Bone
(A) During normal loading (3 represents strain) or ambulation, osteo-
cytes (stellate-shaped cell within bone) send inhibitory signals (red X)
to osteoclasts (blue multinucleated cells on bone surface) to maintain
bone mass, while viable osteocytes are necessary to send signals
activating osteoclasts in response to unloading (3 with red X).
(B) Tatsumi et al. (2007) now show that osteocytes do not play a role in
bone restoration in response to reloading after loss due to unloading. In
the diagram, in the absence of load (3 with red X), the osteocyte sends
signals to the osteoclast to resorb bone. But if the osteocytes are killed
bydiphtheria toxin (DT) injection and then reloaded (3), bone is nonethe-
less regenerated (tan area). However, the 20%–30% viable osteocytes
(spots in bone) remaining after DT injection could still be involved.Cell Metabolism 5, June 2007 ª2007 Elsevier Inc. 411
